Search the TGA website
Website results
These results do not include items from TGA's databases, such as the Database of Adverse Event Notifications, the System for Australian Recall Actions and Medicines Shortages Information.
Fully-matching results
-
AusPAR: Botulinum toxin type A
https://www.tga.gov.au/auspar/auspar-botulinum-toxin-type-120 Nov 2013: AusPAR: Botulinum toxin type A. Large file warning:Attempting to open large files over the Internet within the browser window may cause problems. ... Australian Public Assessment Report. 20 November 2013. AusPAR Details. AusPAR. Active Ingredient.
-
Australian public assessment for Botulinum toxin, type A
https://www.tga.gov.au/sites/default/files/auspar-botulinum-toxin-131023.pdf18 Nov 2013: Therapeutic Goods Administration. AusPAR Botox Botulinum toxin, type A Allergan Australia Pty Ltd PM-2012-01467-3-3 Final 23 October 2013 Page 3 of 64. ... 1 http://www.tga.gov.au/pdf/euguide/ewp001801en.pdf. Therapeutic Goods Administration. AusPAR
-
AusPAR: Botulinum toxin type A
https://www.tga.gov.au/auspar/auspar-botulinum-toxin-type18 Jul 2012: AusPAR: Botulinum toxin type A (pdf, 5 MB). ... Active Ingredient. Botulinum toxin type A. Product Name. Botox. Sponsor. Allergan Australia Pty Ltd.
-
Australian public assessment for Botulinum toxin, type A
https://www.tga.gov.au/sites/default/files/auspar-botulinum-toxin-131023.docx18 Nov 2013: AusPARs are prepared and published by the TGA. An AusPAR is prepared for submissions that relate to new chemical entities, generic medicines, major variations, and extensions of indications. ... gov.au >. Therapeutic Goods Administration. AusPAR Botox
-
Attachment 2. Extract from the Clinical Evaluation Report for…
https://www.tga.gov.au/sites/default/files/auspar-botulinum-toxin-131023-cer.pdf18 Nov 2013: AusPAR Attachment 2. Extract from the Clinical Evaluation Report for Botulinum toxin, type A. ... Botox has also been shown to inhibit various sensory neurotransmitters 3Sponsor correction: local.
-
AusPAR: Botulinum toxin type A
https://www.tga.gov.au/auspar/auspar-botulinum-toxin-type-010 Aug 2011: AusPAR: Botulinum toxin Type A (pdf, 2 MB). ... Active Ingredient. Botulinum toxin type A. Product Name. Botox. Sponsor. Allergan Australia Pty Ltd.
-
Attachment 2. Extract from the Clinical Evaluation Report for…
https://www.tga.gov.au/sites/default/files/auspar-botulinum-toxin-131023-cer.docx18 Nov 2013: AusPAR Attachment 2. Extract from the Clinical Evaluation Report for Botulinum toxin, type A. ... No new information has been submitted to explain the mechanism of action of Botox.
-
Australian Public Assessment Report for Botulinum toxin Type A
https://www.tga.gov.au/sites/default/files/auspar-botox.pdf10 Aug 2011: Therapeutic Goods Administration. AusPAR Botox Botulinum toxin Type A Allergan Australia Pty Ltd PM-2009-03219-3-1 Final 15 June 2011 Page 3 of 121. ... http://www.tga.gov.au/docs/pdf/euguide/ewp/215899en.pdf. Therapeutic Goods Administration. AusPAR
-
Australian public assessment report for Nabiximols
https://www.tga.gov.au/sites/default/files/auspar-nabiximols-130927.pdf19 Nov 2013: About AusPARs An Australian Public Assessment Record (AusPAR) provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve a prescription ... AusPARs are prepared and published by
-
Australian public assessment report for Nabiximols
https://www.tga.gov.au/sites/default/files/auspar-nabiximols-130927.docx19 Nov 2013: To report a problem with a medicine or medical device, please see the information on the TGA website < >. About AusPARs. An Australian Public Assessment Record (AusPAR) provides information about the evaluation ... AusPARs are prepared and published by
